Flow Partners advises Code Pharma

Private placement to undisclosed investors


Jerusalem, Israel — 07 July 2021

Flow Partners acted as a financial advisor to a Dutch biotech and pharmaceutical company Code Pharma facilitating a private placement to undisclosed investors.

About Code Pharma

Founded in 2014, Code Pharma aims to develop cost effective treatments for infectious and oncological diseases by using novel peptides. The company brought together outstanding professionals with multidisciplinary expertise in peptides, cell cultures, clinical development and chemistry manufacturing. Headquatered in Netherlands, Code Pharma acquires peptides from Hebrew University of Jerusalem and keeps its R&D center in Israel.

About Flow Partners

Flow Partners is a new-age technology advisory boutique, providing transaction advice to the companies and investors that shape up the global digital ecosystem. Founded in 2020, the firm operates worldwide and has presence in London, Berlin, Warsaw and Miami. For more information, please visit www.flowpartners.io.


For all enquiries please contact the team at hi@flowpartners.io.